Ardelyx reported $128.02M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Amgen USD 6.19B 39M Mar/2026
Ardelyx USD 128.02M 110.29M Mar/2026
aTyr Pharma USD 2.86M 126.59K Sep/2025
Corcept Therapeutics USD 12.89M 22K Mar/2026
Sanofi EUR 22.69B 1.81B Dec/2025
TG Therapeutics USD 129.03M 3.44M Mar/2026
United Therapeutics USD 178.3M 4.8M Mar/2026